跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,626 条关于
“SR-GT1”
全部
1,626
临床试验
867
药物
629
机构
12
资讯
118
9天前
Redasemtide Clears Ulcer Endpoint in Dystrophic EB but Misses Primary Endpoint in Global Phase 2 Acute Ischemic Stroke Trial
2个月前
Genespire and SR-TIGET Demonstrate Durable Preclinical Efficacy of Liver-Directed Gene Therapy for Methylmalonic Acidemia
去年
FDA Approves Ryoncil, First Mesenchymal Stromal Cell Therapy for Pediatric SR-aGVHD
去年
Mesoblast Awaits FDA Decision on Ryoncil for Pediatric SR-aGvHD
去年
Mesoblast Anticipates FDA Decision on Ryoncil for Pediatric SR-aGvHD by January 2025
去年
Mesoblast Anticipates FDA Decision on Ryoncil for Pediatric SR-aGVHD by January 7, 2025
去年
Mesoblast Anticipates FDA Decision on Ryoncil for Pediatric SR-aGVHD by January 7, 2025
去年
FDA Approves First Systemic Therapy for NRG1 Fusion-Positive Cancers and MSC Therapy for SR-aGVHD
去年
hUC-MSCs Show Promise in Treating Steroid-Refractory Acute Graft-versus-Host Disease
去年
FDA Approves Ryoncil, First Mesenchymal Stromal Cell Therapy for Pediatric Steroid-Refractory Acute Graft-versus-Host Disease
第 1 页,共 12 页
上一页
下一页